Monopar Therapeutics, Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
1.73
0.00 (0.00%)
At close:
Oct 5, 2022 12:00 AM
1.83
+0.10 (5.78%)
null:
Oct 6, 2022 9:29 AM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Market Capitalization
|
22 | 40 | 70 | 173 |
| Market Cap Growth
|
- | -42.34% | -59.48% | - |
| Enterprise Value
|
6 | 20 | 53 | 160 |
| PE Ratio
|
- | -4.44 | -11.12 | -40.94 |
| PB Ratio
|
1.52 | 2.13 | 4.47 | 13.70 |
| Debt / Equity Ratio
|
0.00 | - | - | - |
| Debt / EBITDA Ratio
|
0.00 | - | - | - |
| Debt / FCF Ratio
|
0.00 | - | - | - |
| Current Ratio
|
7.61 | 12.98 | 14.28 | 18.27 |
| Return on Equity (ROE)
|
-57.80% | -41.10% | -43.70% | -60.00% |
| Return on Assets (ROA)
|
-53.20% | -39.00% | -41.60% | -55.60% |
| Return on Capital (ROIC)
|
- | 912.80% | 1440.80% | 2986.20% |
| Earnings Yield
|
-47.10% | -22.50% | -9.00% | -2.40% |
| FCF Yield
|
-35.20% | -18.10% | -6.70% | -1.70% |
| Buyback Yield / Dilution
|
-0.50% | -13.82% | -17.56% | -0.32% |
| Total Shareholder Return
|
-0.50% | -13.82% | -17.56% | -0.32% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).